Caitlin Astbury

Caitlin Astbury is our Research Communications Manager

She is passionate about engaging the MS community with research so people can use scientific evidence to make informed decisions about treatment and care.

Blogs by Caitlin Astbury

The journey of a drug

It takes a long time and lots of hard work to develop a new MS treatment. In 2019, ocrelizumab (brand name Ocrevus) became the first drug to be available for people with primary progressive MS on the NHS.

The clinical trials taking us closer to stopping MS

To help people at every stage of MS, we need to stop MS from progressing. Researchers are looking at three ways to do this. And we’ve now reached the point where there are clinical trials in progress for all three.